A systematic review of p53 as a biomarker of survival in patients with osteosarcoma

Author： Fu Hai-Liang Shao Lin Wang Qiang Jia Tao Li Ming Yang Da-Ping

ISSN： 1010-4283

Source： Tumor Biology, Vol.34, Iss.6, 2013-12, pp. : 3817-3821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is there a specific mutation of p53 gene due to radon exposure? A systematic review

By Ruano-Ravina Alberto Faraldo-Valles Maria Barros-Dios Juan

International Journal of Radiation Biology, Vol. 85, Iss. 7, 2009-07 ,pp. : 614-621

Informa Healthcare

Access to resources Recommend Favorite

Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 495-500

Science Publishers

Access to resources Recommend Favorite

Enhanced Apoptosis Correlates with Poor Survival in Patients with Laryngeal Cancer but not with Cell Proliferation, bcl-2 or p53 Expression

By Hirvikoski P. Kumpulainen E. Virtaniemi J. Pirinen R. Salmi L. Halonen P. Johansson R. Kosma V.-M.

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 231-237

Elsevier

Access to resources Recommend Favorite

Thrombospondin-1 Expression in Epithelial Ovarian Carcinoma: Association with p53 Status, Tumor Angiogenesis, and Survival in Platinum-Treated Patients

By Alvarez A.A. Axelrod J.R. Whitaker R.S. Isner P.D. Bentley R.C. Dodge R.K. Rodriguez G.C.

Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. : 273-278

Elsevier

Access to resources Recommend Favorite

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1611-1615

Spandidos Publications

Access to resources Recommend Favorite